v3.26.3
Revenues and Trade Receivables, Net - Schedule of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Disaggregation of Revenue [Line Items]        
Total revenues $ 7,557 $ 12,807 $ 35,822 $ 31,530
Manufacture and supply revenue        
Disaggregation of Revenue [Line Items]        
Total revenues 6,659 11,467 27,363 28,243
License and royalty revenue        
Disaggregation of Revenue [Line Items]        
Total revenues 824 1,038 7,545 2,667
License and royalty revenue | Zevra And Commave Therapeutics Agreement        
Disaggregation of Revenue [Line Items]        
Total revenues     5,000  
Co-development and research fees        
Disaggregation of Revenue [Line Items]        
Total revenues 74 302 914 1,098
Proprietary product revenue, net        
Disaggregation of Revenue [Line Items]        
Total revenues $ 0 $ 0 $ 0 $ (478)